Swiss Nordic Bio 2026

1 Oct 2026 | Zürich, Switzerland

Register
Register
Register

Circio

Public (listed) SME company

www.circio.comOslo, Norway
23 profile visits

About

Circio is a leading circular RNA biotech based in Norway and Sweden. Circio is developing a novel circular RNA-based gene expression platform, circVec, for next generation gene and cell therapies. The lead programs are in gene therapy for heart, eye and CNS disases and in vivo CAR-T cell therapy.

Areas of Activity

Biotech / Pharma

Therapeutic areas

Cardiology/Vascular DiseasesGenetic DiseaseImmunologyNeurologyOphthalmologyRare Disease

Phase of our company

Preclinical research

We are looking for

Public equity investorPharma innovation scouts & licensing

Representatives

CEO

Circio

CSO

Circio